Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by Bella2017on May 07, 2017 4:09am

176 Views

Post# 26213481

RE:RE:When on earth will Phase 2 approval be announced?

Good point Sunny! Maybe they have been approved and waiting for the right moment to announce it, most likely after May 9.

sunny3999 wrote:
Shadd76 wrote: I heard Easter weekend that it was only a matter of days before they got the green light. What is the delay? How on earth do people expect Phase 3 to be approved in the Fall when it's taken this long to get this phase approved which is 5 times smaller than Phase 3. Come on Health Canada already.

Behind approval for Phase 2 must be more than just this 55,000 sf. Why would Aphria raise $100 mm ?

I assume we will have some good news coming.

Just my 2 cents